How Men Continually Produce Sperm — and How that Discovery Could Help Treat Infertility

Using a leading-edge technique, researchers define the cell types in both newborn and adult human testes, opening a path for new strategies to treat male infertility with stem cells

February 05, 2019  |  

​The production of sperm — otherwise known as spermatogenesis — generates more than 1,000 sperm per second in normal males. This productivity comes, in part, from a special cell type called the spermatogonial stem cell. The staying power of this stem cell has allowed many celebrities, including Robert DeNiro and Pablo Picasso, to father children after the age of 65.

Yet spermatogonial stem cells have not been well studied in humans, and attempts to grow them in the lab for clinical purposes have had limited success. In a study published February 5, 2019 in Cell Reports, researchers at University of California San Diego School of Medicine used a technique called single-cell RNA sequencing to develop a clearer picture of human spermatogonial stem cells and how sperm are formed. They also developed tools to better isolate these stem cells.

spermatogonial stem cells

UC San Diego School of Medicine researchers identified several sperm cell subtypes and biomarkers that will help them isolate spermatogonial stem cells. Click here to view larger version

This advance, the researchers write, opens the possibility that spermatogonial stem cell transplants could be developed to treat male infertility, an issue that affects more than 100 million men worldwide.

“Single-cell RNA sequencing determines the activity of hundreds of genes in the genomes of single cells,” said senior author Miles Wilkinson, PhD, professor in the Department of Obstetrics, Gynecology and Reproductive Sciences at UC San Diego School of Medicine. “Because each cell type has a different combination of active genes, this technique allows new cell types to be identified. Applying this approach to the testis, we uncovered many different stages of sperm precursor cells in human testes.”

In adult human testes, the researchers identified several cell subtypes that likely include spermatogonial stem cells. They also found cells with the characteristics of spermatogonial stem cells in human newborns.

“Given that spermatogonial stem cells are not necessary for generating sperm until puberty, this finding in newborns raises the possibility that these cells perform as-of-yet unknown functions in infants and young children,” Wilkinson said.

Their study also identified many unique molecules — biomarkers — that define spermatogonial stem cells. These biomarkers, which they detected with specific antibodies, allowed the researchers to efficiently capture human spermatogonial stem cells.

Wilkinson’s team also identified the genes active in other cells that support spermatogonial stem cells. The finding may help researchers develop protein cocktails that drive spermatogonial stem cell proliferation in the laboratory, and allow them to scale up enough of the cells for clinical applications.

“This was a proof-of-principal for future clinical studies to use spermatogonial stem cell therapy as a means to treat men suffering from infertility, including cancer patients rendered infertile by chemotherapy,” said Wilkinson.

Co-authors of this study also include: Abhishek Sohni, Kun Tan, Hye-Won Song, Dana Burow, Louise Laurent, Tung-Chin Hsieh, UC San Diego; Dirk G. de Rooij, Utrecht University; Raja Rabah, Michigan Medicine, CS Mott and VonVoigtlander Women’s Hospitals; Saher Sue Hammoud, University of Michigan Medical School; and Elena Vicini, Sapienza University of Rome.

This research was funded, in part, by the National Institutes of Health (R01GM119128, T32HD007203) and Lalor Institute.




Media Contact

Heather Buschman, PhD
858-249-0456
hbuschman@ucsd.edu

Share This Article


Related News

5/9/2019
Using stem cells derived from six people, UC San Diego School of Medicine researchers recapitulated retinal cells in the lab. This “eye-in-a-dish” model allowed them to identify genetic variants that ...
4/29/2019
Two renowned research centers at University of California San Diego are joining forces to take a deeper look at how components of human milk and the microbiome can change the course of therapeutics fo ...
4/4/2019
An international team of scientists led by researchers at University of California San Diego School of Medicine employed an array of next-generation sequencing and gene-editing tools, such as CRISPR, ...
8/11/2014
During pregnancy, certain hormones trigger specialized mammary stem cells to create milk-producing cells essential to lactation. Scientists at the University of California, San Diego School of Medicin ...



Follow Us